Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Elrose Labs

Elrose Labs
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a medical product designed to treat Molluscum disease. The company's product is based in a blend of phytochemical and antiviral compounds found in nature which helps to remove lesions and pain from the disease easily, enabling users to get relief from this disease within one to two weeks.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Primary Office
  • 3875 St Johns Parkway
  • Sanford, FL 32771
  • United States

+1 (855) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Elrose Labs’s full profile, request a free trial.

Elrose Labs Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Elrose Labs Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
University of Central Florida Business Incubator Accelerator/Incubator Minority 000 0000 000000 0

Elrose Labs Executive Team (3)

Name Title Board
Seat
Contact
Info
James Ragsdale Chief Executive Officer
Sass Robert Chief Financial Officer
Paul Konz Chief Operating Officer